{"id":"https://openalex.org/W2052270403","doi":"https://doi.org/10.3111/13696998.2015.1040024","title":"Cost-effectiveness of sofosbuvir plus ribavirin with or without pegylated interferon for the treatment of chronic hepatitis C in Italy","display_name":"Cost-effectiveness of sofosbuvir plus ribavirin with or without pegylated interferon for the treatment of chronic hepatitis C in Italy","publication_year":2015,"publication_date":"2015-04-20","ids":{"openalex":"https://openalex.org/W2052270403","doi":"https://doi.org/10.3111/13696998.2015.1040024","mag":"2052270403","pmid":"https://pubmed.ncbi.nlm.nih.gov/25891129"},"language":"en","primary_location":{"id":"doi:10.3111/13696998.2015.1040024","doi":"https://doi.org/10.3111/13696998.2015.1040024","is_oa":true,"landing_page_url":"https://doi.org/10.3111/13696998.2015.1040024","pdf_url":"https://www.tandfonline.com/doi/pdf/10.3111/13696998.2015.1040024?needAccess=true","source":{"id":"https://openalex.org/S155267287","display_name":"Journal of Medical Economics","issn_l":"1369-6998","issn":["1369-6998","1941-837X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["abdc-c","anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320449","host_organization_name":"Informa","host_organization_lineage":["https://openalex.org/P4310320449"],"host_organization_lineage_names":["Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Medical Economics","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2052270403"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://www.tandfonline.com/doi/pdf/10.3111/13696998.2015.1040024?needAccess=true","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5019652605","display_name":"Sandrine Cure","orcid":"https://orcid.org/0000-0002-8296-0771","observed_orcids":["https://orcid.org/0000-0002-8296-0771"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sandrine Cure","raw_affiliation_strings":["a a Mapi , Uxbridge , UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"a a Mapi , Uxbridge , UK","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102877922","display_name":"I. Guerra","orcid":"https://orcid.org/0009-0005-5544-7509","observed_orcids":["https://orcid.org/0009-0005-5544-7509"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Ines Guerra","raw_affiliation_strings":["Mapi, Uxbridge, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mapi, Uxbridge, UK","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013334772","display_name":"Calogero Camm\u00e0","orcid":"https://orcid.org/0000-0002-9224-1914","observed_orcids":["https://orcid.org/0000-0002-9224-1914"]},"institutions":[{"id":"https://openalex.org/I900890020","display_name":"University of Palermo","ror":"https://ror.org/044k9ta02","country_code":"IT","type":"education","lineage":["https://openalex.org/I900890020"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Calogero Camm\u00e0","raw_affiliation_strings":["Dipartimento Biomedico di Medicina Interna e Specialistica & UOC Gastroenterologia & Epatologia, DiBiMIS, Universit\u00e0 di Palermo, Palermo, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dipartimento Biomedico di Medicina Interna e Specialistica & UOC Gastroenterologia & Epatologia, DiBiMIS, Universit\u00e0 di Palermo, Palermo, Italy","institution_ids":["https://openalex.org/I900890020"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100684562","display_name":"Antonio Crax\u00ec","orcid":"https://orcid.org/0000-0002-4480-9544","observed_orcids":["https://orcid.org/0000-0002-4480-9544"]},"institutions":[{"id":"https://openalex.org/I900890020","display_name":"University of Palermo","ror":"https://ror.org/044k9ta02","country_code":"IT","type":"education","lineage":["https://openalex.org/I900890020"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Antonio Crax\u00ec","raw_affiliation_strings":["Dipartimento Biomedico di Medicina Interna e Specialistica & UOC Gastroenterologia & Epatologia, DiBiMIS, Universit\u00e0 di Palermo, Palermo, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dipartimento Biomedico di Medicina Interna e Specialistica & UOC Gastroenterologia & Epatologia, DiBiMIS, Universit\u00e0 di Palermo, Palermo, Italy","institution_ids":["https://openalex.org/I900890020"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5068517502","display_name":"Giampiero Carosi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I79940851","display_name":"University of Brescia","ror":"https://ror.org/02q2d2610","country_code":"IT","type":"education","lineage":["https://openalex.org/I79940851"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Giampiero Carosi","raw_affiliation_strings":["Institute of Infectious Diseases, University of Brescia, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Infectious Diseases, University of Brescia, Italy","institution_ids":["https://openalex.org/I79940851"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5102877922"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":3.5607,"has_fulltext":true,"cited_by_count":26,"citation_normalized_percentile":{"value":0.93646302,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":87,"max":99},"biblio":{"volume":"18","issue":"9","first_page":"678","last_page":"690"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10151","display_name":"Hepatitis C virus research","score":0.9643999934196472,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10151","display_name":"Hepatitis C virus research","score":0.9643999934196472,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.0348999984562397,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/sofosbuvir","display_name":"sofosbuvir","score":0.8740000128746033},{"id":"https://openalex.org/keywords/ribavirin","display_name":"ribavirin","score":0.9919999837875366},{"id":"https://openalex.org/keywords/pegylated-interferon","display_name":"pegylated interferon","score":0.9950000047683716},{"id":"https://openalex.org/keywords/chronic-hepatitis-c","display_name":"chronic hepatitis C","score":0.9739999771118164},{"id":"https://openalex.org/keywords/cost-effectiveness","display_name":"cost-effectiveness","score":0.9459999799728394},{"id":"https://openalex.org/keywords/hcv-genotype-1-6","display_name":"HCV genotype 1-6","score":0.7990000247955322},{"id":"https://openalex.org/keywords/interferon-free-therapy","display_name":"interferon-free therapy","score":0.6159999966621399},{"id":"https://openalex.org/keywords/hepatitis-c-cirrhosis","display_name":"hepatitis C cirrhosis","score":0.6940000057220459},{"id":"https://openalex.org/keywords/sustained-virologic-response","display_name":"sustained virological response","score":0.828000009059906},{"id":"https://openalex.org/keywords/italy","display_name":"Italy","score":0.3109999895095825}],"concepts":[{"id":"https://openalex.org/C2778390639","wikidata":"https://www.wikidata.org/wiki/Q2502747","display_name":"Sofosbuvir","level":5,"score":0.960540771484375},{"id":"https://openalex.org/C2780040827","wikidata":"https://www.wikidata.org/wiki/Q421862","display_name":"Ribavirin","level":4,"score":0.9464173316955566},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9400769472122192},{"id":"https://openalex.org/C2776461080","wikidata":"https://www.wikidata.org/wiki/Q7160835","display_name":"Pegylated interferon","level":5,"score":0.8705456256866455},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5925650596618652},{"id":"https://openalex.org/C2776455275","wikidata":"https://www.wikidata.org/wiki/Q154869","display_name":"Hepatitis C","level":2,"score":0.5621854066848755},{"id":"https://openalex.org/C2776408679","wikidata":"https://www.wikidata.org/wiki/Q708693","display_name":"Hepatitis C virus","level":3,"score":0.5083276629447937},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.49088364839553833},{"id":"https://openalex.org/C2776178377","wikidata":"https://www.wikidata.org/wiki/Q188269","display_name":"Interferon","level":2,"score":0.4771794080734253},{"id":"https://openalex.org/C3020491458","wikidata":"https://www.wikidata.org/wiki/Q131742","display_name":"Chronic hepatitis","level":3,"score":0.47044649720191956},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.455594539642334},{"id":"https://openalex.org/C3019080777","wikidata":"https://www.wikidata.org/wiki/Q1754768","display_name":"Cost effectiveness","level":2,"score":0.44512978196144104},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.385525107383728},{"id":"https://openalex.org/C2522874641","wikidata":"https://www.wikidata.org/wiki/Q808","display_name":"Virus","level":2,"score":0.2190750539302826},{"id":"https://openalex.org/C112930515","wikidata":"https://www.wikidata.org/wiki/Q4389547","display_name":"Risk analysis (engineering)","level":1,"score":0.0},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000069474","descriptor_name":"Sofosbuvir","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000069474","descriptor_name":"Sofosbuvir","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000998","descriptor_name":"Antiviral Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000998","descriptor_name":"Antiviral Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D003362","descriptor_name":"Cost-Benefit Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005838","descriptor_name":"Genotype","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007558","descriptor_name":"Italy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008390","descriptor_name":"Markov Chains","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010342","descriptor_name":"Patient Acceptance of Health Care","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011092","descriptor_name":"Polyethylene Glycols","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012254","descriptor_name":"Ribavirin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D012254","descriptor_name":"Ribavirin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D012720","descriptor_name":"Severity of Illness Index","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016898","descriptor_name":"Interferon-alpha","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D016898","descriptor_name":"Interferon-alpha","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D019057","descriptor_name":"Quality-Adjusted Life Years","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019698","descriptor_name":"Hepatitis C, Chronic","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D019698","descriptor_name":"Hepatitis C, Chronic","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.3111/13696998.2015.1040024","doi":"https://doi.org/10.3111/13696998.2015.1040024","is_oa":true,"landing_page_url":"https://doi.org/10.3111/13696998.2015.1040024","pdf_url":"https://www.tandfonline.com/doi/pdf/10.3111/13696998.2015.1040024?needAccess=true","source":{"id":"https://openalex.org/S155267287","display_name":"Journal of Medical Economics","issn_l":"1369-6998","issn":["1369-6998","1941-837X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["abdc-c","anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320449","host_organization_name":"Informa","host_organization_lineage":["https://openalex.org/P4310320449"],"host_organization_lineage_names":["Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Medical Economics","raw_type":"journal-article"},{"id":"pmid:25891129","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/25891129","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of medical economics","raw_type":"Journal Article"},{"id":"pmh:oai:iris.unipa.it:10447/401771","doi":null,"is_oa":false,"landing_page_url":"http://hdl.handle.net/10447/401771","pdf_url":null,"source":{"id":"https://openalex.org/S4306401065","display_name":"Nova Science Publishers (Nova Science Publishers, Inc.)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":{"id":"doi:10.3111/13696998.2015.1040024","doi":"https://doi.org/10.3111/13696998.2015.1040024","is_oa":true,"landing_page_url":"https://doi.org/10.3111/13696998.2015.1040024","pdf_url":"https://www.tandfonline.com/doi/pdf/10.3111/13696998.2015.1040024?needAccess=true","source":{"id":"https://openalex.org/S155267287","display_name":"Journal of Medical Economics","issn_l":"1369-6998","issn":["1369-6998","1941-837X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["abdc-c","anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320449","host_organization_name":"Informa","host_organization_lineage":["https://openalex.org/P4310320449"],"host_organization_lineage_names":["Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Medical Economics","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9922999739646912}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320320903","display_name":"Atsumi International Scholarship Foundation","ror":"https://ror.org/0574ytm77"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2052270403.pdf","grobid_xml":"https://content.openalex.org/works/W2052270403.grobid-xml"},"referenced_works_count":30,"referenced_works":["https://openalex.org/W77270962","https://openalex.org/W1504384931","https://openalex.org/W1588369580","https://openalex.org/W1981170530","https://openalex.org/W1984445589","https://openalex.org/W1987012521","https://openalex.org/W1996796934","https://openalex.org/W2016278419","https://openalex.org/W2019262762","https://openalex.org/W2027047118","https://openalex.org/W2027442554","https://openalex.org/W2038936672","https://openalex.org/W2041643208","https://openalex.org/W2055855527","https://openalex.org/W2058200448","https://openalex.org/W2060528034","https://openalex.org/W2068790832","https://openalex.org/W2075282196","https://openalex.org/W2078450406","https://openalex.org/W2080420644","https://openalex.org/W2085764459","https://openalex.org/W2088567273","https://openalex.org/W2092052931","https://openalex.org/W2101533631","https://openalex.org/W2104010560","https://openalex.org/W2121603373","https://openalex.org/W2127685726","https://openalex.org/W2133694748","https://openalex.org/W2172225052","https://openalex.org/W4210961054"],"related_works":["https://openalex.org/W2082066550","https://openalex.org/W1996796934","https://openalex.org/W6921021073","https://openalex.org/W2102193571","https://openalex.org/W1910533708","https://openalex.org/W3048454001","https://openalex.org/W2101533631","https://openalex.org/W1992531459","https://openalex.org/W2104366268","https://openalex.org/W2060528034"],"abstract_inverted_index":{"OBJECTIVE:":[0],"Across":[1],"Italy":[2],"up":[3],"to":[4,35,250,256,293],"7.3%":[5],"of":[6,113,130,141,145,185,218,232,242,287,298],"the":[7,54,60,94,109,151,180,186,223,235,240,268,296],"population":[8,247],"is":[9,59,92,248],"infected":[10],"with":[11,16,65,70,74,196],"hepatitis":[12],"C":[13],"virus":[14],"(HCV),":[15],"long-term":[17],"complications":[18],"resulting":[19],"in":[20,81,118,190,203,208,244,264,300],"high":[21,284],"medical":[22],"costs":[23],"and":[24,27,40,45,73,143,162,173,179,227],"significant":[25],"morbidity":[26],"mortality.":[28],"Current":[29],"treatment":[30,43,96,149,278,290],"options":[31],"have":[32],"limitations":[33],"due":[34],"side":[36],"effects,":[37],"interferon":[38,78,104],"intolerability":[39],"ineligibility,":[41],"long":[42],"durations":[44],"low":[46],"sustained":[47],"virological":[48],"response":[49],"(SVR)":[50],"rates,":[51],"especially":[52],"for":[53,98,103,115,159,167,214,228,267,280],"most":[55,269],"severe":[56,270],"patients).":[57],"Sofosbuvir":[58,193],"first":[61,95],"nucleotide":[62],"polymerase":[63],"inhibitor":[64],"pan-genotypic":[66],"activity.":[67],"Sofosbuvir,":[68],"administered":[69],"ribavirin":[71],"(RBV)":[72],"or":[75,165,169],"without":[76],"pegylated":[77],"(PEG-INF),":[79],"resulted":[80],">90%":[82],"SVR":[83],"across":[84],"treatment-na\u00efve":[85],"(TN)":[86],"genotype":[87],"(GT)":[88],"1-6":[89,117],"patients.":[90,210,271,282],"It":[91],"also":[93],"option":[97,279],"patients":[99,132,147,221],"that":[100,184],"are":[101,262,275,291],"unsuitable":[102],"(UI).":[105],"This":[106],"analysis":[107],"evaluates":[108],"cost":[110,181],"-":[111],"effectiveness":[112],"sofosbuvir":[114],"GTs":[116,161],"Italy.":[119,191,301],"RESEARCH":[120],"DESIGN":[121],"AND":[122],"METHODS:":[123],"A":[124],"Markov":[125],"model":[126],"followed":[127],"a":[128,215,229,276],"cohort":[129,217,231],"10,000":[131],"until":[133],"they":[134],"reached":[135],"80":[136],"years":[137],"old.":[138],"Approximately":[139],"20%":[140],"na\u00efve":[142],"30%":[144],"experienced":[146],"initiated":[148],"at":[150,177],"cirrhosis":[152],"stage.":[153],"Comparators":[154],"included":[155],"PEG-INF":[156],"+":[157],"RBV":[158],"all":[160,204],"plus":[163],"telaprevir":[164],"boceprevir":[166],"GT1,":[168],"no":[170],"treatment.":[171],"Costs":[172],"outcomes":[174],"were":[175,254],"discounted":[176],"3%":[178],"perspective":[182],"was":[183,194,213,225,237],"National":[187],"Health":[188],"Service":[189],"RESULTS:":[192],"cost-effective":[195,263],"incremental":[197],"cost-effectiveness":[198],"ratios":[199],"(ICERs)":[200],"below":[201],"\u20ac40,000/QALY":[202],"patient":[205,246],"populations,":[206],"particularly":[207],"cirrhotic":[209,230],"The":[211,272,283],"exception":[212],"mixed":[216],"GT2":[219],"TN":[220],"where":[222,234],"ICER":[224,236],"\u20ac68,500/QALY":[226],"GT4/5/6":[233],"\u20ac68,434/QALY.":[238],"Nevertheless,":[239],"prevalence":[241],"HCV":[243,299],"this":[245,288],"expected":[249,292],"be":[251],"low.":[252],"Results":[253],"robust":[255],"sensitivity":[257],"analysis.":[258],"CONCLUSIONS:":[259],"Sofosbuvir-based":[260],"regimens":[261,274],"Italy,":[265],"particular":[266],"interferon-free":[273],"real":[277],"UI":[281],"cure":[285],"rates":[286],"breakthrough":[289],"substantially":[294],"reduce":[295],"burden":[297]},"counts_by_year":[{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2018,"cited_by_count":5},{"year":2017,"cited_by_count":4},{"year":2016,"cited_by_count":11},{"year":2015,"cited_by_count":2}],"updated_date":"2026-11-14T11:04:58.165337","created_date":"2016-06-24T00:00:00"}